Videos

Preeya Gupta, MD, discusses the results of a study evaluating the safety and efficacy of KPI-121 0.25% for the treatment of dry eye disease. 

Safety and efficacy of KPI-121 0.25% for DED treatment

Michael R. Robinson, MD, Allergan, discusses the results from a study analyzing an investigational ophthalmic solution for treatment of symptoms associated with presbyopia presented during the virtual AAO 2020 meeting.

Analyzing an investigational ophthalmic solution for treating presbyopia-related symptoms

Tanner Ferguson, MD, Cole Eye Institute, discusses findings from the study "Trabecular Micro-bypass Stent Implantation (iStent)" + Phacoemulsification in PXG: Six-Year Outcomes," during the virtual AAO 2020 meeting. 

Evaluating long-term safety of micro-bypass implant + phaco in PXG

Daniel H. Chang, MD, speaks on the highlights of his presentation on "Violet Light-Filtering IOLs: Visual and Non-Visual Benefits," during the virtual AAO 2020 meeting.

Violet light-filtering IOLs: visual and non-visual benefits

John A. Hovanesian, MD, discusses the highlights of his presentation on a clinical study evaluating dexamethasone vs prednisolone acetate 1% in controlling postop pain/inflammation in sequential cataract surgery patients.

Drug delivery vs drops: Controlling postop pain, inflammation in cataract patients

Michael R. Robinson, MD, shares the highlights of the study "Single administration of intracameral bimatoprost implant 10 µg: IOP lowering and safety," presented during the virtual AAO 2020 meeting.

Single administration of intracameral bimatoprost implant: IOP lowering, safety

A panel of experts in ophthalmology and optometry review the diagnosis and treatment of diabetic eye disease including emerging agents in the field.

Updates in DME, diabetic retinopathy

Davinder Grover, MD, MPH, speaks on the highlights of his presentation regarding outcomes of a 12-year study comparing ab externo vs ab interno xen gel stents in tertiary glaucoma practice. 

AAO 2020: Comparing outcomes of xen gel stents in glaucoma practice

Caroline R Baumal, MD, Thomas Albini, MD, Aleksandra Rachitskaya, MD, and Michael Singer, MD, discuss a number of topics pertaining to wet age-related macular degeneration (wet AMD) including the diagnosis and clinical manifestations, treatment options, and the impact of the COVID-19 pandemic on management of wet AMD.
  

Advancement in the management of wet AMD

Robert Weinstock, MD, presents data from a retrospective multicenter study focusing on the efficacy of dexamethasone intraocular suspension 9% delivered at the time of cataract surgery. 


Expert Interviews